innoscripta SE
XETRA:1INN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
innoscripta SE
XETRA:1INN
|
DE |
|
D
|
Deutsche Telekom AG
OTC:DTEGF
|
DE |
|
N
|
Nomadar Corp
NASDAQ:NOMA
|
US |
|
C
|
CytRx Corp
LSE:0I5R
|
US |
|
Liberty Defense Holdings Ltd
F:LD2A
|
US |
|
G
|
Golden Globe Resources Ltd
ASX:GGR
|
AU |
|
Emmvee Photovoltaic Power Ltd
NSE:EMMVEE
|
IN |
|
Piccadily Agro Industries Ltd
NSE:PICCADIL
|
IN |
|
S
|
Synovus Financial Corp
SWB:SYU1
|
US |
|
Western Gold Exploration Ltd
XTSX:WGLD
|
CA |
|
G
|
Good Fellow Healthcare Holdings Ltd
HKEX:8598
|
HK |
Wall Street
Price Targets
1INN Price Targets Summary
innoscripta SE
According to Wall Street analysts, the average 1-year price target for 1INN is 216.75 EUR with a low forecast of 202 EUR and a high forecast of 236.25 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 1INN's stock price target?
Price Target
216.75
EUR
According to Wall Street analysts, the average 1-year price target for 1INN is 216.75 EUR with a low forecast of 202 EUR and a high forecast of 236.25 EUR.
What is innoscripta SE's Revenue forecast?
Projected CAGR
39%
The compound annual growth rate of innoscripta SE's revenue for the next 4 years is 39%.
What is innoscripta SE's Operating Income forecast?
Projected CAGR
40%
The compound annual growth rate of innoscripta SE's operating income for the next 4 years is 40%.
What is innoscripta SE's Net Income forecast?
Projected CAGR
40%
The compound annual growth rate of innoscripta SE's net income for the next 4 years is 40%.
